New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 15, 2013
08:08 EDTMNTAMomenta Pharma stills sees 2013 operating cash use about $90M
Momenta confirmed its guidance, previously provided in November, for total operating expenses, excluding stock-based compensation and net of collaborative revenues, of approximately $30M per quarter in 2013. For 2013, Momenta is projecting that its net cash usage will average approximately $20M-$24M per quarter for a total operating cash usage of approximately $90M.
News For MNTA From The Last 14 Days
Check below for free stories on MNTA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for MNTA

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use